Development of a method for assessing the depth of penetration of ethosomes with methylene blue into the skin during application and photodynamic exposure

A wide range of literature sources report on the potential benefits of transdermal drug delivery. Among these advantages, the following are distinguished – minimal injury, reduction of side effects, and prevention of degradation or metabolism in the gastrointestinal tract or liver. However, transdermal delivery of most molecules often excludes due to the barrier function of the skin, which prevents the penetration of exogenous substances. To overcome this barrier and increase skin absorption, ethosomal complexes use, by means penetration into the deep layers of the skin and/or systemic circulation is possible. This work devotes to the development of a non-invasive method for assessing the depth of penetration by ethosomes with methylene blue (MB) into the skin during application and photodynamic exposure. MB as photosensitizer (PS) was chosen, since there are a sufficient number of publications on its positive effect on the restoration of the cell’s respiratory chain of various organs and therefore the restoration of their metabolism. Besides MB has proven to be an effective PS, destructed pathogenic microbes and viruses, including SARS-CoV-2. However, for more effective Covid-19 therapy and antibiotic-resistant microbial diseases, the penetration of MB into the vascular system of the epidermis or mucous tissue is required. Nowadays, the existing methods for assessing the penetration depth of PS are time consuming and require the use of animal skin or model samples. The LESA-01 BIOSPEC system with specially designed optical adapters that allow assessing the drug fluorescence intensity on skin surface and at a depth of up to 2 mm in the investigation was used.

1. Shepty O. The use of lidocaine / prilocaine anesthetic cream for laser procedures in dermatology and cosmetology, Russian Journal of Clinical Dermatology and Venereology, 2020, vol. 19, pp. 113-120.

2. Stranadko E.F., Volgin V.N., Lamotkin I.A. Photodynamic therapy of basal cell skin cancer with photosensitizer photoditazine, International Journal of Applied and Fundamental Research, 2008, pp. 152-162.

3. Goldberg D. J. Photodynamic therapy in skin rejuvenation, Clinics in Dermatology, 2008, vol. 26(6), pp. 608-613.

4. Sigrid K., Elisabeth K., Konstantin F. et al. Photodynamic therapy for skin rejuvenation: review and summary of the literature – results of a consensus conference of an expert group for aesthetic photodynamic therapy, JDDG, 2013, vol. 11(2), pp. 137-148.

5. Tardivo J.P., Giglio A.D., Carla Santos de Oliveira D.S.G. et al. Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications, Photodiagnosis and Photodynamic Therapy, 2005, vol. 2(3), pp. 175-191.

6. Zhengmei X., O’Donovan M., Linlin Sun et al. Anti-Aging Potentials of Methylene Blue for Human Skin Longevity, Scientific Reports, 2017, vol. 7, p. 5.

7. Petrat F., Pindiur S., Kirsch M. et al. NAD(P)H, a Primary Target of 1O2 in Mitochondria of Intact Cells*, Journal of Biological Chemistry, 2003, vol. 278(5), pp. 3298-3307.

8. Kessel D., Luo Y. Mitochondrial photodamage and PDT induced apoptosis, J Photochem Photobiol B:Biol, 1998, vol. 42, pp. 89-95.

9. Godin B., Touitou E. Ethosomes: New Prospects in Transdermal Delivery, Critical Reviewstrade; in Therapeutic Drug Carrier Systems, 2003, vol. 20(1).

10. Bunting J. R. A test of the singlet oxygen mechanism of cationic dye photosensitization of mitochondrial damage, Photochem Photobiol, 1992, vol. 2, pp. 81-87.

11. Johnson P.G., Gallo S.A., Hui S.W. et al. A Pulsed Electric Field Enhances Cutaneous Delivery of Methylene Blue in Excised Full-Thickness Porcine Skin, Journal of Investigative Dermatology, 1998, vol. 111(3), pp. 457–463.

12. Schreier H., Bouwstra J. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery, Journal of Controlled Release, 1994, vol. 30(1), pp. 1-15.

13. Lane M. Skin penetration enhancers, International journal of pharmaceutics, 2013, vol. 2, p. 447.

14. Lademann J., Richter H., Schanzer S. et al. Penetration and storage of particles in human skin: perspectives and safety aspects, Eur J Pharm Biopharm, 2010, vol. 77, (3), pp. 465-468.

15. E. Touitou. Drug delivery across the skin, Expert Opin Biol Ther, 2002, vol. 2, pp. 723-733.

16. Mezei M. Gulasekharam Vijeyalakshmi. Liposomes–a selective drug delivery system for the topical route of administration. Lotion dosage form, Life sciences, 1980, vol. 26, pp. 1473-1477.

17. Mezei M., Gulasekharam V., Liposomes – A selective drug delivery system for the topical route of administration: gel dosage form, Journal of Pharmacy and Pharmacology, 1982, vol. 34(7), pp. 473-474.

18. Egbaria K., Weiner N.D. Liposomes as a topical drug delivery system, Advanced Drug Delivery Reviews, 1990, vol. 5, pp. 287-300.

19. Touitou E., Levi-Schaffer F., Nava Dayan et.al. Modulation of caffeine skin delivery by carrier design: liposomes versus permeation enhancers, International Journal of Pharmaceutics, 1994, vol. 103, pp. 131-136.

20. Touitou E., Dayan N., Bergelson L. et.al. Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties, Journal of controlled release official journal of the Controlled Release Society, 2000, vol. 65(3).

21. Cevc G., Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes, Biochimica et Biophysica Acta (BBA) – Biomembranes, 2001, vol. 1514, pp. 191-205.